Detalhe da pesquisa
1.
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.
Breast Cancer Res Treat
; 185(3): 741-758, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179154
2.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
Breast Cancer Res Treat
; 180(3): 675-685, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124136
3.
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer.
Acta Oncol
; 59(6): 713-722, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32141389
4.
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
Int J Cancer
; 145(5): 1325-1333, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30748011
5.
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
Int J Cancer
; 145(1): 274-283, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30588619
6.
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG).
Breast Cancer Res Treat
; 172(2): 413-423, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30121808
7.
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
Lancet Oncol
; 18(11): 1502-1511, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29031778
8.
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
Cancer
; 122(19): 2961-70, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27315546
9.
Expected survival with and without second-line palliative chemotherapy: who wants to know?
Health Expect
; 18(6): 2903-14, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25302963
10.
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial.
EClinicalMedicine
; 58: 101901, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992863
11.
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
JNCI Cancer Spectr
; 7(6)2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991939
12.
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.
Nat Commun
; 11(1): 3083, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32576828
13.
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.
J Natl Cancer Inst
; 109(12)2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29546343
14.
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.
Cancer Chemother Pharmacol
; 78(4): 875-80, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544765
15.
Weekly docetaxel in metastatic breast cancer patients: no superior benefits compared to three-weekly docetaxel.
Eur J Cancer
; 47(9): 1355-62, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21251813
16.
FDG hepatic superscan caused by massive breast cancer invasion.
Clin Nucl Med
; 34(10): 716-8, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19893412